References:

Alio, S. F. (1997). Long term expression of the human alpha1 antitrypsin gene in mice employing anionic and cationic liposome vector. Biochemical Pharmacology 54: 9-13.

Al-Saadi, S. A., Clements, G. B. and Subak-Sharpe, J. H. (1983). Viral genes modify herpes simplex virus latency both in mouse footpad and sensory ganglia. Journal of General Virology 64: 1175-1179.

Andreansky, S. S., He, B., Gillespie, G. Y., Soroceanu, L., Market, J., Chou, J., Roizman., B. and Whitley, R. J. (1996). The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proceedings of the National Academy of Sciences USA 93: 11313-11318.

Andreansky, S. S., Sorcoceanu, L., Flotte, E. R., Chou, J., Markert, J. M., Gillespie, G. Y., Roizman, B. and Whitley, R. J. (1997). Evaluation of genetically engineered herpes simplex virus as oncolytic agents for human malignant brain tumours. Cancer Research 57: 1502-1509.

Armentano, D., Zabner, J., Sacks, C., Sookdeo, C. C., Smith, M. P., St. George, J. A., Wadsworth, S. C., Smith, A. E. and Gregory, R. J. (1997). Effect of the E4 region on the presistence of transgene expression from adenovirus vectors. Journal of Virology 71: 2408-2416.

Barnes, M. N., Deshane, J. S, Rosenfield, M., Siegal, G. P., Curiel, D. T. and Alvarez, R. D. (1997). Gene therapy and ovarian cancer: a review. Obstetrics and Gynecology 89: 145-155.

Beerli, R., Winfried, W. and Hynes, N. (1994). Intracellular expression of single chain antibodies reverts erbB2 transformation. Journal of Biological Chemistry 269: 23931-23936

Bergelson, J. M., Cunningham J. A., Droguett, G., Kurt-Jones, A. E., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., and Finberg, R. W. (1997). Isolation of a common receptor for coxsackie virus B viruses and adenoviruses 2 and 5. Science 275: 1320-1323.

Blmer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M. and Gage, F. H. (1997). Highly efficient and sustained gene transfer in adult neurones with a lentivirus vector. Journal of Virology 71: 6641-6649.

Budker, V., Zhang, G., Danko, I., Williams, P. and Wolff, J. (1998). The efficient expression of intravascularly delivered DNA in rat muscle. Gene Therapy 5: 272-276.

Burns, J. C., Matsubara, T., Lozinski, G., Yee, J., Freidmann, T., Washabaugh, C. H. and Tsonis, P. A. (1994). Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells. Developmental Biology 165: 285-289.

Caruso, M. and Bank A. (1997). Efficient retroviral gene transfer of a Tat-regulated herpes simplex virus thymidine kinase gene for HIV therapy. Virus Research 52: 133-143.

Champlin, P., Kavanagh, J. and Deisseroth, A. (1994). Use of safety modified retrovirus to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial. Human Gene Therapy 5: 1507-1522.

Chen, L., Ashe, S., Brady, W. A., Hellstrm, I., Hellstrm, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. (1992). Costimulation of antitumour immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4. Cell 71: 1093-4220.

Chen, L., Chen, D., Manome, Y., Dong, Y., Fine, H. A., and Kufe, D. W. (1995). Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. Journal of Clinical Investigation 96: 2775-2282.

Chen, H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S. and Clemens, P. R. (1997). Persistence in muscle of an adenoviral vector that lacks all viral genes. Proceedings of the National Academy of Sciences of the U.S.A. 94: 1645-1650.

Cheng, L., Ziegelhoffer, P. R. and Yang, N. S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proceedings of the National Academy of Sciences of the U.S.A. 90: 4455-4459.

Collins, J., Herman, P., Schuch, C. and Babgy, G. (1992). cmyc antisence oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. Journal of Clinical Investigation 89: 1523-1527.

Corr. M., Tighe, H., Lee. D., Dudler, J., Trieu, M., Brinson, D. C. and Carson, D. A. (1997). Costimulation provided by DNA immunisation enhances antitumor immunity. The Journal of Laboratory Investigation 159: 4999-5004.

Contassot, E., Ferrand, C., Certoux, J., Reynolds, C. W., Jacob, W., Chiang, Y., Cahn, J., Herv P. and Tiberghien. P. (1988). Retrovirus-mediated transfer of the herpes simplex type 1 thymidine kinase gene in alloreactive T lymphocytes. Human Gene Therapy 9: 73-80.

Davison, E., Diaz, R. M., Hart, I. R., Santis, G. and Marshall, J. F. (1997). Integrin a5b1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. Journal of Virology 71: 6204-6207.

Diaz, R. M., Eisen, T., Hart, I. R. and Vile, R. G. (1998). Exchange of viral promotor/enhancer elements with regulatory sequences generated targeted hybrid long terminal repeat vectors for gene therapy of melanoma. Journal of Virology 72: 789-795.

Disis, M., Smith, J., Murphy, A., Chen, W., and Cheever, M. (1994). In vitro generation of human cytolytic T-cells specific for peptides derived from the HER2/neu protooncogene protein. Cancer Research 54: 59-65.

During, M. J., Naegele, J. R., OMalley, K. L. and Geller, A. I. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1403.

Dzau, J. V., Mann, M. J, Morishita, R. and Kaneda, Y. (1996). Fusigenic viral liposome for gene therapy in cardiovascular disease. Proceedings of the National Academy of Sciences USA 93: 11421-11425.

Ebbinghouse, S., Gee, J., Rodu, B., Mayfield, C., and Miller, D. (1993). Triplex formation inhibits HER2/ neu transcription in vitro. Journal of Clinical Investigation 92: 2433-2439.

Engelhardt, J. F., Litsky, L., and Wilson, J. M. (1994). Prolonged gene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Human Gene Therapy 5: 1217-1229.

Federoff, H. J., Geschwind, M. D., Geller, A. I. and Kessler, J. A. (1992). Expression of nerve factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proceedings of the National Academy of Sciences USA 89: 1636-1640.

Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tasi, Y. J., Border, R., Ramsey, P., Martin, M. and Felgner, P. L. (1994). Enhanced gene delivery system and mechanism studies with a novel series of cationic lipid formulations. Journal of Biological Chemistry 269: 2550-2561.

Ferkol, T., Kaetzel, C. S. and Davis, P. B. (1993). Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobin receptor. Journal of Clinical Investigation 92: 2394-2400.

Ferry, N., Duplessis, O., Houssin, D., Danos, O. and Heard, J. (1991). Retroviral mediated gene transfer into hepatocytes in vivo. Proceedings of the National Academy of Sciences USA 88: 8377-8381.

Fisher, K. J., Kelley, W. M, Burda, J. F. and Wilson, J. M. (1996). A novel adenovirus-adeno-associated virus hybrid vector that displays efficient resue and delivery og the AAV genome. Human Gene Therapy 7: 2079-2087.

Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E. and Wilson, J. M. (1997). Recombinant adeno-associated virus for muscle directed gene delivery. Nature Medicine 3: 306-316.

Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B. and Roth, J. A. (1993). A retroviral wild-type p53 expression vector penetrates human lung cancer spheriods and inhibits growth by inducing apootosis. Cancer Research 53: 4129-4133.

Gahry-Sdard, H., Molinier-Frenkel, V., Le Boulaire, C., Saulnier, P., Opolon, P., Lengange, R., Gautier, E., Le Cesne, A., Zitvogel, L., Venet, A., Schatz, C., Courtney, M., Le Chevalier, T., Tursz, T., Guillet, J. and Farace, F. (1997). Phase I trial of recombinant adenovirus gene transfer in lung cancer. Journal of Clinical Investigation 100: 2218-2226.

Geddes, B. J., Harding, T. C., Lightman, S. L. and Uney, J. B. (1997). Long term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nature Medicine 3: 1402-1404.

Geller, A. I., During, M. J., Oh, J. Y., Freese, F. and OMalley, K. (1995). An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-DOPA from cultured rat striatal cells. Journal of Neurochemistry 64: 487-496.

Gerard, R. D. and Collen, D. (1997). Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis. Cardiovascular Research 35: 451-458.

Ghazizadeh, S., Carroll, J., M. and Taichman L. B. (1997). Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. Journal of Virology 71: 9163-9169.

Glimm, H., Kiem, H. P., Darovsky, B., Storb, R., Wolf, J., Diehl, V., Mertelsmann, R. and Kalle, C. V. (1997). Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long term exposure to GALV-pseudotyped retroviral vector. Human Gene Therapy 8: 2079-2086.

Glorioso, J. C., DeLuca, N. A. and Fink, D. J (1995). Development and application of herpes simplex virus vectors for human gene therapy. Annual Review of Microbiology 49: 675-710.

Goldfine. I. D., German, M. S., Tseng, H., Wang, J., Bolaffi, J. L., Chen, J. Olson, D. C. and Rothman, S. S. (1997). The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nature Biotechnology 15: 1378-1382.

Goldman, C. K., Rogers, B. E., Douglas, J. T., Sonsowski, B. A., Ying, W., Siegal, G. P., Baird, A., Campain, J. A. and Curiel, D. T (1997). Targeted gene delivery to karposis sarcoma cells via the fibroblast growth factor receptor. Cancer Research 57: 1447-1451.

Graham, F. L., Smiley, J., Russell, W. L. and Nairn, R. (1997). Characterization of a human cell line transformation by DNA from adenovirus 5. General Virology 36: 59-72.

Hallahan, D. E., Mauceri, H. J., Seung, L. P., Dunphy, E. J., Wayne, J. D., Hannia, N. N., Toledano, A., Hellman, S., Kufe, D. W., Weichselbaum, R. R. (1995). Spatial and temporal control of gene therapy using ionizing radiation. Nature Medicine 8: 786-791.

Harris, J. D. and Lemoine, N. R. (1996). Strategies for targeted gene therapy. Trends in Genetics 12: 400-404.

Hartikka, J., Sawdey, M., Conefert-Jensen, F., Margalith, M., Barnhardt, K., Nolasco, M., Vahlsing, H. L., Meek, J., Marquet, M., Hobart, P., Norman, J. and Manthorpe, M. (1996). An improved plasmid DNA expression vector for direct injection into skeletal muscle. Human Gene Therapy 7: 1205-1217.

Herzog, R. W., Hagstrom, J. N., Kung, S., Tai, S. J., Wilson, J. M., Fisher, K. J. and High, K. A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proceedings of the National Academy of Sciences of the U.S.A. 94: 5804-5809.

Hong, S. S., Karayan, L., Tournier, J., Curiel, D. T., and Boulanger, P. A. (1997). Adenovirus type 5 fiber knob binds to MHC class I a2 domain at the surface of human epithelial and B lymphoblastiod cells. EMBO Journal 16: 2294-2306.

Hu, S., Ji, W., Zhou, Y., Logothetis, C. and Xu, H. (1997). Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression. Cancer Research 57: 3339-3343.

Jobin, C., Panja, A., Hellerbrand, C., Iimuro, Y., Didonato, J., Brenner, D. A. and Sartor, R. B. (1998). Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kB super-repressor in human intestinal epithelial cells. The Journal of Immunology 160: 410-418.

Jooss, K., Yang, Y. and Wilson, J. M. (1996). Cyclophosphamide diminishes inflammation and prolongs expression following delivery of adenoviral vectors to mouse liver and lung. Human Gene Therapy 7: 1555-1566.

Jooss, K., Ertl, H. C. J. and Wilson, J. M. (1998). Cytotoxic T-lymphocyte target proteins and their histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. Journal of Virology 72: 2945-2954.

Kafri, T., Blmer, U., Peterson, D. A., Gage, F. H. and Verma, I. M. (1997). Sustained expression of genes delivered into liver and muscle by lentiviral vectors. Nature Genetics 17: 314-317.

Kagami, H., Atkinson, J. C., Michalek, S. M., Handelman, B., Yu, S., Baum, B. J. and O'Connell, B. (1998). Repetitive adenovirus administration to the parotid gland: role of immunolgical barriers and induction of oral tolerance. Human Gene Therapy 9: 305-313.

Kasahara, N., Dozy, A. M. and Kan, Y. W. (1994). Tissue-specific targetting of retroviral ligand-receptor interactions. Science 266: 1374-1376.

Kay, M. A., Meuse, L., Gown, A. M., Linsley, P., Hollenbaugh, D., Aruffo, A., Ochs, H. D. and Wilson, C. B. (1997). Transient immunomodulation with anti-CD40 ligand and CTLA41g enhances presistence and secondary adenovirus-mediated gene transfer into mouse liver. Proceedings of the National Academy of Sciences of the U.S.A. 94: 4686-4691.

Kennedy, P. G. E. (1997). Potential uses of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. Brain 120: 1245-1259.

Kesari, S., Randazzo, B. P., Valyi-Nagy, T., Huang, Q. S., Brown, S. M., MacLean, A. R., Lee, V. M., Trojanowski, J. Q. and Fraser, N. W. (1995). Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. laboratory Investigation 73: 636-648.

Kim, S., Lin, H., Barr, E., Chu, L., Leiden, J. M. and Parmacek, M. S. (1997). Transcriptional targetting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. Journal of Clinical Investigation 100: 1006-1014.

Kim, S. H., Yu, S. S., Park, J. S, Robbins, P. D, An, C. S. and Kim, S. (1998). Construction of retroviral vectors with improved safety, gene expression, and versitility. Journal of Virology 72: 994-1004.

Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M. and Berns, K. I. (1990). Site-specific integration by adeno-associated virus. Proceedings of the National Academy of Sciences of the U.S.A. 87: 2211-2215.

Kramm, C. M., Chase, M., Herrlinger, U., Jacobs, A., Pechan, P. A., Rainov, N. G., Sena-esteves, M., Aghi, M. Barnett, F. H., Chiocca, E. A. and Breakefield, X.. O. (1997). Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Human Gene Therapy 8: 2057-2068.

Kucharczuk, J. C., Randazzo, B., Chang, M. Y., Amin, K. M., Elshami, A. A., Sterman, D. H., Rizk, N. P., Molnar-Kimber, K. L., Brown, S. M., MacLean, A. R., Litzky, L. A., Fraser, N. W., Albelda, S. M. and Kaiser, L. R. (1997). Use of a replication-restricted herpes virus to treat experimental human malignant mesothelioma. Cancer Research 57: 466-471.

Lemig, T., Brenner, M., Ramsey, J., Vanin, E., Blaese, M. and Dilloo, D. (1996). High-efficiency transduction of freshly isolated tumor cells using adenoviral interleukin-2 vectors. Human Gene Therapy 7: 1233-1239.

Lekutis, C., Shiver, J. W., Liu, M. A., and Letvin, L. N. (1997). HIV1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFNg and TNFa. The Journal of Immunology 158: 4471-4477.

Lozier, J. N., Yankaskas, J. R, Ramsey, W. J., Chen, L., Berschneider, H. and Morgan, R. A. (1997). Gut epithelial cells as targets for gene therapy of hemophilia. Human Gene Therapy 8: 1481-1490.

Maeda, Y., Ikeda, U., Ogasawara, Y., Urabe, M., Takizawa, T., Saito, T., Colosi, P., Kurtzman, G., Shimada, K. and Ozawa, K. (1997). Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. Cardiovascular Research 35: 514-521.

Macklin, M. D., McCabe, D., McGregor, M. W., Neumann, V., Meyer, T., Callan, R., Hinshaw, V. S. and Swain, W. S. (1998). Immunization of pigs with a particle mediated vaccine to influenza A virus protects against challenge with homologous virus. Journal of Virology 72: 1491-1496.

Manickan, E., Karem, K. L., and Rouse, B. T. (1997). DNA vacines - a modern gimmick or a boon to vaccinology. Critical Reviews in Immunology 17: 139-154.

Madon, J. and Blum, H. E. (1996). Receptor mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells. Hepatology 24: 474-481.

Marconi, P., Krisky, D., Oligino, T., Poliani, P. L., Ramakrishnan, R., Goins, W. F., Fink, D. A. and Glorioso, J. C. (1996). Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proceedings of the National Academy of Sciences USA 93: 11319-11320.

Markowitz, D., Goff, S. and Bank, A. (1988). A safe packaging line for gene transfer: separating viral genes on two different plasmids. Journal of Virology 62: 1120-1124.

Miyatake, S., Iyer, A., Martuza, R. L. and Rabkin, S. D. (1997). Transcriptional targeting of herpes simplex virus for cell specific replication. Journal of Virology 71: 5124-5132.

Miyoshi, H., Takahashi, M., Gage, F. H. and Verma, I. M. (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proceedings of the National Academy of Sciences of the U.S.A. 94: 10319-10323.

Naldini, L., Blmer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma I. M. and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.

Neda, H., Wu, C. H., and Wu. G. Y. (1991). Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity. The Journal of Biological Chemistry 266: 14143-14146.

Numes, F. A. and Raper, S. E. (1996). Liver-directed gene therapy. Medical Clinics of North America 80: 1201-1213.

Ogawa, N., Fujiwara, T., Kagawa, S., Nishizaki, M., Morimoto, Y., Tanida, T., Hizuta, A., Yasuda, T.,, Roth, J. A. and Tanaka, N. (1997). Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chenotherapeutic agent. International Journal of Cancer 73: 367-370.

Oldfield, E. H. and Ram, Z. (1995). Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. Human Gene Therapy 6: 55-85.

Ozaki, K., Yoshida, T., Ide, H., Saito, I., Ikeda, Y., Sugimura, T. and Terada, M. (1996). Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC. Human Gene Therapy 7: 1483-1490.

Paillard, F. (1998). Suicide against brain tumors. Human Gene Therapy 9: 3-4.

Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J. and Bromberg, J. S. (1997). Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Human Gene Therapy 8: 2019-2029.

Qing, K., Bachelot, T., Mukherjee, P., Wang, X., Peng, L., Yoder, M. C., Leboulch, P. and Srivastava, A. (1997). Adeno-associated virus type 2 mediated transfer of ecotropic retrovirus receptor cDNA allows ecotropic retroviral transduction of established and primary human cells. Journal of Virology 71: 5663-5667.

Rivire, I., Brose, K. and Mulligan, R. C. (1995). Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proceedings of the National Academy of Sciences of the U.S.A. 92: 6733-6737.

Rollins, S. A., Birks, C. W., Setter, E., Squinto, S, P. and Rother R. P. (1996). Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response. Human Gene Therapy 7: 619-626.

Rome, J. J., Shayani, V., Newman, K. D., Farrell, S., Lee, S. W., Virmani, R. and Dicheck, D. A. (1994). Adenoviral vector mediated gene transfer into sheep arteries using a double-balloon catheter. Human Gene Therapy 5: 1249-1258.

Roth, J. A. and Cristiano, R. J. (1997). Gene therapy for cancer: what have we done and where are we going? Journal of the National Cancer Institute 89: 21-38.

Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T. and Cai, D. (1996). Retrovirus mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Medicine 2: 985-991.

Rother, P. R., William, L. F., Springhorn, J. P., Birks, W. C., Sandrin, M. S., Squinto, S. P. and Rollins, S. A. (1995). A novel mechanism of retrovirus inactivation in human serum mediated by anti-a-galactosyl natural antibody. Journal of Experimental Medicine 182: 1345-1355.

Roux, P., Jeanteur, P., and Piechaczyk, M. (1989). A versatile and potentially general approach to the targeting of specific cell types by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proceedings of the National Academy of Sciences USA 86: 9079-9083.

Rutledge, E. A. and Russell, D. W. (1997). Adeno-associated virus vector integration junctions. Journal of Virology 71: 8429-8436.

Saleh, M. (1997). A retroviral vector that allows co-expression of two genes and the versatility of alternate selection markers. Human Gene Therapy 8: 979-983.

Samulski, R. J., Chang, L., and Shenk, T. (1989). Helper free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. Journal of Virology 63: 3822-3828.

Sawtell, N. M. and Thompson, R. L. (1992). Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependant establishment and reactivation from latency. Journal of Virology 66: 2157-2169.

Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L. and Kochanek, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Genetics 18: 180-183.

Shi, Q., Wang, Y. and Worton, R. (1997). Modulation of the specificity and activity of a cellular promotor in an adenoviral vector. Human Gene Therapy 8: 403-410.

Skarli, M., Kiri, A., Vrbova, G., Lee, C. A. and Goldspink, G. (1998). Myosin regulatory elements as vectors for gene transfer by intramuscular injection. Gene Therapy 5: 514-520.

Smith, A. E. (1995). Viral vectors in gene therapy. Annual Review of Microbiology 49: 807-838.

Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swiderski, P., Kaplan, B. E., and Forman, S. J. (1993). Ribozyme mediated inhibition of BCRABL gene expression in a Philadelphia positive cell line. Blood 82: 600-605.

Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winter, B., Meuse, L., Cohen, L. K., Thompson, A. R. and Kay, M. A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genetics 16: 270-275.

Sparer, T. E., Wynn, S. G., Clark, D. J., Kaplan, J. M., Cardoza, L. M., Wadsworth, S. C., Smith, A. E. and Gooding, L. R. (1997). Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. Journal of Virology 71: 2277-2284.

Steiner, I., Spivack, J. G., Lirette, R. P., Brown, S. M., MacLean, A. R., Subak-Sharpe, J. H. and Fraser, N. W. (1989). Herpes simplex virus type 1 latency-associated transcripts are evidently not evidently not essential for latent infection. EMBO Journal 8: 505-511.

Stavridis, J. C., Deliconstantinos, G., Psallidopoulos, M. C., Armenakas, N. S., Hadjiminas, D. J. and Hadjiminas J. (1986). Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits. Experimental Cell Research 164: 568-572.

Suzuki, M., Singh, R. N. and Crystal, R. G. (1996). Regulatable promotors for use in gene therapy applications: modifications of the 5-flanking region of the CFTR gene with multiple cAMP reponse elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP. Human Gene Therapy 7: 1883-1893.

Tait, D. L., Obermiller, P. S., Redlin-Frazier, S., Jensen, R. A., Welcsh, P., Dann, J., King, M, Johnson, D. H. and Holt, J. T. (1997). A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer. Clinical Cancer Research 3: 1959-1968.

Takeshita, S., Tsurumi, Y., Couffinahl, T., Asahara, T., Bauters, C., Symes, J., Ferrara, N., and Isner, J. M. (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor endothelial growth factor stimulates collateral development in vivo. Laboratory Investigation 75: 487-501.

Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, J. J., Gromkowski, S. H., Deck, R., DeWitt, C. M., Friedman, A., Hawe, L. A., Laender, K. R., Martinz, D., Perry, H. C., Shiver, J. Montgomery, D. L. and Liu, M. A. (1993). Heterologous protection against influenza by ingection of DNA encoding a viral protein. Science 254: 1745-1749.

Verma, I. M. and Somia, N. (1997). Gene therapy - promises, problems and prospects. Nature 389: 239-242.

Vincent, K. A, Piraino, S. T. and Wadsworth, S. C. (1997). Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. Journal of Virology 71: 1897-1905.

Wagner, E., Cotten, M., Foisner, R. and Birnstiel, M. L. (1991). Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proceedings of the National Academy of Sciences USA 88: 4255-4259.

Wang, C., and Huang, L. (1987). pH sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proceedings of the National Academy of Sciences USA 84: 7851-7855.

Wang, S. and Vos, J. (1996). A hybrid herpesvirus infectious vector based on epstein-barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. Journal of Virology 70: 8422-8430.

Wen, P., Crawford, N. and Locker, J. (1993). A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers. Nucleic Acids Research 21: 1911-1918.

Wheeler, C. J., Felgner, P. L., Tsai, Y. J., Marshall, J., Sukhu, L., Soeun, G. H., Hartikka, J., Nietupski, J., Manthorpe, M., Nichols, M., Plewe, M., Liang, X., Norman, J., Smith, A. and Cheng, S. H. (1996). A novel cationic lipid greatly enhances plasmid delivery and expression in mouse lung. Proceedings of the National Academy of Sciences USA 93: 11454-11459.

Wickham, T. J., Mathias, P., Cheresh, D. A., and Nemerow, G. R. (1993). Integrins avb3 and avb5 promote adenovirus internalisation but not virus attachment. Cell 73: 309-319.

Wickham, T. J., Tzeng, E., Shears II, L. L., Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonova, A. and Kovesdi, I. (1997a). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. Journal of Virology 71: 8221-8229.

Wickham, T. J., Lee, G. M, Titus, J. A., Titus, J. A., Sconocchia, G., Bakacs, T., Kovesdi, I. and Segal, D. M. (1997b). Targeted adenovirus-mediated gene delivery to T cells via CD3. Journal of Virology 71: 7663-7669.

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner P. L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.

Wood, M. J. A., Byrnes, A. P., Pfaff, D. W., Rabkin, S. D. and Charlton, H. M. (1994). Inflammatory effects of gene-transfer into the CNS with defective HSV-1 vectors. Gene Therapy 1: 283-291.

Worgall, S., Wolff, G., Falck-Pedersen, E. and Crystal R. G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Human Gene Therapy 8: 37-44.

Wu, C. H., Wilson, J. M. and Wu., G. Y. (1989). Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. Journal of Biological Chemistry. 264: 16985-16987.

Wygoda, M. R., Wilson, M. R., Davis, M. A., Trosko, J. E., Rehemtulla, A. and Lawrence, T. S. (1997). Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by ystander cells: the good samaritan effect. Cancer Research 57: 1699-1703.

Xiang, Z. and Ertl, H. C. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2: 129-135.

Xiao, X., Li, J. and Samulski, R. J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. Journal of Virology 72: 2224-2232.

Yang, Y. and Wilson, J. M. (1995). Clearance of adenovirus-infected hepatocytes by MHC class I restricted CD4+ CTLs in vivo. Journal of Immmunology 155: 2564-2569.

Yannelli, J., Hyatt, C. , Johnston, S., Hwu, P. and Rosenberg, S. (1993). Characterisation of human tumour cell lines transduced with the cDNA encoding either tumour necrosis factor a or interleukin2 (IL2). Journal of Immunological Methods 161: 77-90.

York, I. A., Roop, C., Andrews, D. W., Riddell, R., Graham., F. L., and Johnson, D. C. (1994). A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77: 525-535.

^TOP^

<<< Previous Section

© MicrobiologyBytes 2004.